Your browser doesn't support javascript.
loading
A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease.
Howell, T H; Fiorellini, J P; Paquette, D W; Offenbacher, S; Giannobile, W V; Lynch, S E.
Affiliation
  • Howell TH; Department of Periodontology, Harvard School of Dental Medicine, Boston, MA, USA.
J Periodontol ; 68(12): 1186-93, 1997 Dec.
Article in En | MEDLINE | ID: mdl-9444594
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Derived Growth Factor / Insulin-Like Growth Factor I / Furcation Defects Type of study: Clinical_trials / Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Periodontol Year: 1997 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Derived Growth Factor / Insulin-Like Growth Factor I / Furcation Defects Type of study: Clinical_trials / Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Periodontol Year: 1997 Document type: Article Affiliation country: United States Country of publication: United States